Hjem › Blærecancer › Washington › Seattle
Blærecancer kliniske forsøg i Seattle, WA
21 studier for Blærecancer søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- og 1 flere
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RekruttererFase 2
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RekruttererFase 2
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- University of Washington Medical Center - Montlake, Seattle
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
RekruttererFase 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruttererFase 1/2
- Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
- Eye Associates Northwest - First Hill Clinic, Seattle
- Harborview Medical Center, Seattle
- og 3 flere
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
- Swedish Cancer Institute, Seattle
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
RekruttererFase 3
- Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RekruttererFase 1/2
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Rekrutterer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
RekruttererFase 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
RekruttererObservationsstudie
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RekruttererFase 2/3
- Local Institution - 0200, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- University of Washington School of Medicine, Seattle
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
RekruttererFase 3
- Research Site, Seattle
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruttererFase 2
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Rekrutterer
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
Blue Light Cystoscopy With Cysview® Registry
RekruttererObservationsstudie
- University of Washington Medicine, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Seattle
Blærecancer forsøg i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Edison, NJ21 studier
- Chicago, IL21 studier
Andre studier i Seattle
- Ikke-småcellet lungecancer53 studier
- Kræft (alle typer)49 studier
- Prostatakræft42 studier
- Akut myeloid leukæmi40 studier
- Brystkræft39 studier
- Metastatisk cancer39 studier
- Colorektal kræft34 studier
- Lungecancer33 studier
- Ægstockræft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukæmi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.